tiprankstipranks
Trending News
More News >
Dr. Reddy's Laboratories Ltd (RDY)
:RDY
Advertisement

Dr. Reddy's Laboratories Ltd

Compare
444 Followers

RDY Stock Chart & Stats

$14.75
$0.11(0.67%)
At close: 4:00 PM EST
$14.75
$0.11(0.67%)

Dr Reddy's Laboratories News

RDY FAQ

What was Dr. Reddy's Laboratories Ltd’s price range in the past 12 months?
Dr. Reddy's Laboratories Ltd lowest stock price was $12.26 and its highest was $16.17 in the past 12 months.
    What is Dr. Reddy's Laboratories Ltd’s market cap?
    Dr. Reddy's Laboratories Ltd’s market cap is $12.20B.
      When is Dr. Reddy's Laboratories Ltd’s upcoming earnings report date?
      Dr. Reddy's Laboratories Ltd’s upcoming earnings report date is Jan 23, 2026 which is in 86 days.
        How were Dr. Reddy's Laboratories Ltd’s earnings last quarter?
        Dr. Reddy's Laboratories Ltd released its earnings results on Oct 24, 2025. The company reported $0.197 earnings per share for the quarter, beating the consensus estimate of $0.193 by $0.004.
          Is Dr. Reddy's Laboratories Ltd overvalued?
          According to Wall Street analysts Dr. Reddy's Laboratories Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Dr. Reddy's Laboratories Ltd pay dividends?
            Dr. Reddy's Laboratories Ltd pays a Annually dividend of $0.091 which represents an annual dividend yield of 0.63%. See more information on Dr. Reddy's Laboratories Ltd dividends here
              What is Dr. Reddy's Laboratories Ltd’s EPS estimate?
              Dr. Reddy's Laboratories Ltd’s EPS estimate is 0.16.
                How many shares outstanding does Dr. Reddy's Laboratories Ltd have?
                Dr. Reddy's Laboratories Ltd has 834,574,700 shares outstanding.
                  What happened to Dr. Reddy's Laboratories Ltd’s price movement after its last earnings report?
                  Dr. Reddy's Laboratories Ltd reported an EPS of $0.197 in its last earnings report, beating expectations of $0.193. Following the earnings report the stock price went down -0.274%.
                    Which hedge fund is a major shareholder of Dr. Reddy's Laboratories Ltd?
                    Currently, no hedge funds are holding shares in RDY

                    Company Description

                    Dr. Reddy's Laboratories Ltd

                    Dr. Reddy's Laboratories (RDY) is a global pharmaceutical company based in India, engaged in the development and manufacturing of a wide range of pharmaceutical products, including generics, branded medications, and active pharmaceutical ingredients (APIs). The company operates across several therapeutic areas, including oncology, cardiovascular, and gastrointestinal, and serves markets in India, the United States, Europe, and other emerging economies. Dr. Reddy's is committed to providing affordable healthcare solutions through its innovative and high-quality products.

                    Dr Reddy's Laboratories (RDY) Earnings & Revenues

                    RDY Company Deck

                    RDY Earnings Call

                    Q2 2025
                    0:00 / 0:00
                    Earnings Call Sentiment|Neutral
                    The earnings call presented a mixed performance with significant revenue growth in various markets and strategic acquisitions, contrasted by challenges in the U.S. generics market, regulatory hurdles, and decreased margins.View all RDY earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Viatris
                    Neurocrine
                    Perrigo Company
                    Teva Pharmaceutical
                    Amneal Pharmaceuticals

                    Ownership Overview

                    1.05%0.02%98.09%
                    Insiders
                    0.02% Other Institutional Investors
                    98.09% Public Companies and
                    Individual Investors
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis